Page last updated: 2024-09-03
elacridar and Granulocytic Leukemia
elacridar has been researched along with Granulocytic Leukemia in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
den Ouden, D; Schoester, M; Sonneveld, P; van den Heuvel, M; van Rens, G | 1 |
Other Studies
1 other study(ies) available for elacridar and Granulocytic Leukemia
Article | Year |
---|---|
In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.
Topics: Acridines; Acute Disease; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Humans; Isoquinolines; Kinetics; Leukemia, Myeloid; Multiple Myeloma; Neoplasm Proteins; Polymerase Chain Reaction; Rhodamine 123; Rhodamines; Tetrahydroisoquinolines; Transcription, Genetic; Tumor Cells, Cultured | 1996 |